DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 33.00
0.00 (0.00%)
Aug 18, 2026, 1:30 PM CST
DIVA Laboratories Market Cap
DIVA Laboratories has a market cap or net worth of 1.94 billion as of August 18, 2026. Its market cap has decreased by -19.22% in one year.
Market Cap
1.94B
Enterprise Value
1.39B
Revenue
894.67M
Ranking
n/a
PE Ratio
20.24
Stock Price
33.00
ChartMarket Cap Chart
Since October 11, 2010, DIVA Laboratories's market cap has increased from 425.72M to 1.94B, an increase of 354.77%. That is a compound annual growth rate of 10.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 1.94B | -5.44% |
| Dec 31, 2025 | 2.05B | -8.76% |
| Dec 31, 2024 | 2.24B | 3.94% |
| Dec 29, 2023 | 2.16B | -9.25% |
| Dec 30, 2022 | 2.38B | 51.31% |
| Dec 30, 2021 | 1.57B | 8.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.00B |
| Puriblood Medical | 1.11B |
| Genetics Generation Advancement | 1.05B |
| Kim Forest Enterprise | 775.93M |
| Sofiva Genomics | 726.62M |
| TFBS Bioscience | 719.75M |
| Welgene Biotech | 391.51M |
| Pharmigene | 353.26M |